Skip to main content

Table 3 Drug resistance of gram-negative bacilli [% (cases)]

From: Pathogenic bacteria distributions and drug resistance analysis in 96 cases of neonatal sepsis

 

E. coli

Klebsiella pneumoniae subsp.

Others

Sum

Gentamicin

33.3 (2/6)

40.0 (4/10)

66.7 (2/3)

42.1 (8/19)

SMZ

66.7 (4/6)

50.0 (5/10)

33.3 (1/3)

52.6 (10/19)

Amoxicillin

83.3 (5/6)

100.0 (7/7)

100.0 (2/2)

93.3 (14/15)

Piperacillin

50.0 (3/6)

100.0 (7/7)a

66.7 (2/3)

75.0 (12/16)

Piperacillin/Tazobactam

16.7 (1/6)

80.0 (8/10)

100.0 (2/2)a

61.1 (11/18)

Cefoxitin

33.3 (2/6)

100.0 (7/7)a

100.0 (2/2)a

73.3 (11/15)

Ceftazidime

33.3 (2/6)

100.0 (10/10)

66.7 (2/3)

73.7 (14/19)

Cefepime

33.3 (2/6)

100.0 (10/10)

66.7 (2/3)

73.7 (14/19)

Cefuroxime

50.0 (3/6)

100.0 (7/7)

66.7 (2/3)

75.0 (12/16)

Meropenem

0.0 (0/6)

0.0 (0/7)a

50.0 (1/2)a

6.7 (1/15)

Imipenem

0.0 (0/6)

30.0 (3/10)

33.3 (1/3)

21.1 (4/19)

Amikacin

0.0 (0/6)

0.0 (0/10)

0.0 (0/3)

0.0 (0/19)

Amoxicillin/clavulanate

33.3 (2/6)

100.0 (7/7)a

100.0 (2/2)a

73.3 (11/15)

Cefalotin

50.0 (3/6)

70.0 (7/10)

100.0 (2/2)a

66.7 (12/18)

Cefotaxime

33.3 (2/6)

100.0 (7/7)a

66.7 (2/3)

68.8 (11/16)

Tobramycin

50.0 (3/6)

10.0 (1/10)

100.0 (2/2)

33.3 (6/18)

  1. Note: 1. a: partial strains were not tested sensitivity to this drug, the denominator inside parentheses was the actual bacterial strains tested sensitivity to this drug. 2. The drug-resistant strains in this study referred to those with drug resistance (R) and interim strain (I)